Glucocorticoid medication, memory and steroid psychosis in medical illness

Annals of the New York Academy of Sciences

Volumn 823, Issue , 1997, Pages 81-96

  Wolkowitz, Owen M ^a   Reus, Victor I ^a   Canick, Jonathan ^b   Levin, Bronson ^c   Lupien, Sonia ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c Potomac Center   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; DEXAMETHASONE; FENFLURAMINE; GLUCOCORTICOID; HYDROCORTISONE; NEUROLEPTIC AGENT; PHENTERMINE; PRASTERONE; PREDNISONE; VALPROIC ACID;

ADULT; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; HUMAN; HYPERCORTISOLISM; MALE; MEMORY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PSYCHOSIS; RISK FACTOR; WITHDRAWAL SYNDROME;

EID: 0030850243     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48381.x     Document Type: Conference Paper

References (99)

1. HALL, R. C. W., M. K. POPKIN, S. K. STICKNEY & E. R. GARDNER. 1979. Presentation of the steroid psychoses. J. Nerv. Ment. Dis. 167: 229.
2. LING, M. H. M., P. J. PERRY & M. T. TSUANG. 1981. Side effects of corticosteroid therapy. Arch. Gen. Psychiatry 18: 471-477.
3. WOLKOWITZ, O. M., D. R. RUBINOW, A. R. DORAN, A. BREIER, W. H. BERRETTINI, M. A. KLING & D. PICKAR. 1990. Prednisone effects on neurochemistry and behavior. Arch. Gen. Psychiatry 47: 963-968.
4. SMYLLIE, H. C. & C. K. CONNOLLY. 1968. Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 23: 571-581.
5. SERGENT, J. S., M. D. LOCKSHIN, M. S. KLEMPNER & B. A. LIPSKY. 1975. Central nervous system disease in systemic lupus erythematosus. Am. J. Med. 58: 644-654.
6. CADE, R., G. SPOONER, E. SCHLEIN, A. PICKERING, A. DEQUASADA, A. HOLCOMB, L. JUNCOS, G. RICHARD, D. SHIRES, D. LEVINE, R. HACKETT, J. FREE, R. HUNT & M. FREGLY. 1973. Comparison of azathioprine, prednisone and heparin alone or combined in treated lupus nephritis. Nephron 10: 37-56.
7. GOOLKER, P. & J. SCHEIN. 1953. Psychic effects of ACTH and cortisone. Psychosom. Med. 15: 589-612.
8. DENBURG, S. D., R. M. CARBOTTE & J. A. DENBURG. 1994. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 37: 1311-1320.
9. BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM. 1972. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Ther. 13: 694-698.
10. TRAVLOS, A. & G. HIRSCH. 1993. Steroid psychosis: A cause of confusion on the acute spinal cord injury unit. Arch. Phys. Med. Rehabil. 74: 312-315.
11. WYSENBECK, A. J., L. LEIBOVICI & J. ZOLDAN. 1990. Acute central nervous system complications of pulse steroid therapy in patients with SLE. J. Rheumatol. 17: 12: 1695-1696.
12. WOLHEIM, F. A. 1984. Acute and long term complications of corticosteroid pulse therapy. Scand. J. Rheumatol. 54: 27-32.
13. LEWIS, D. A. & R. E. SMITH. 1983. Steroid induced psychiatric syndromes. J. Affective Dis. 5: 319-332.
14. ALCENA, V. & G. S. ALEXOPOULOS. 1985. Ulcerative colitis in association with chronic paranoid schizophrenia: A review of steroid-induced psychiatric disorders. J. Clin. Gastroenterol. 7: 400-404.
15. SCHRAA, J. C. & J. F. DIRKS. 1982. The influence of corticosteroids and theophylline on cerebral function. Chest 82(2): 181-185.
16. KEENAN, P. A., M. W. JACOBSON, R. M. SOLEYMANI & J. W. NEWCOMER. 1995. Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann. N.Y. Acad. Sci. 761: 400-402.
17. MAURI, M., E. SINFORIANI, G. BONO, F. VIGNATI, M. E. BERSELLI, R. ATTANASIO & G. NAPPI. 1993. Memory impairment in Cushing's disease. Acta Neurol. Scand. 87: 52-55.
18. SAPOLSKY, R. M., L. C. KREY & B. S. MCEWEN. 1985. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J. Neurosci. 5: 1222-1227.
19. KERR, D. S., L. W. CAMPBELL, S. Y. HAO & P. W. LANDFIELD. 1989. Corticosteroid modulation of hippocampal potentials: Increased effect with aging. Science 245: 1505-1509.
20. LEVY, A., S. DACHIR, I. ARBEL & T. KADAR. 1994. Aging, stress, and cognitive function. Ann. N.Y. Acad. Sci. 717: 79-88.
21. LANDFIELD, P. W. & J. C. ELDRIDGE. 1994. The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: Role of dysregulated intraneuronal calcium. Ann. N.Y. Acad. Sci. 746: 308-326.
22. MARTIGNONI, E., A. COSTA, E. SINFORIANI, A. LUIZZI, P. CHIODINI, M. MAURI, G. BOND & G. NAPPI. 1992. The brain as a target for adrenocortical steroids: Cognitive implications. Psychoneuroendocrinology 17: 343-354.
23. VARNEY, N. R., B. ALEXANDER & J. H. MACINDOE. 1984. Reversible steroid dementia in patients without steroid psychosis. Am. J. Psychiatry 141: 369-372.
24. NABER, D., P. SAND & B. HIEGL. 1996. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21: 25-31.
25. PERRY, P. J., M. T. TSUANG & M. H. HWANG. 1984. Prednisone psychosis: Clinical observations. Drug Intell. Clin. Pharm. 18: 603-609.
26. BENDER, B. G., J. A. LEMER & J. E. POLAND. 1991. Association between corticosteroids and psychological changes in hospitalized asthmatic children. Ann. Allergy 66: 414-419.
27. LEZAK, M. D. 1995. Neuropsychological assessment (Third Edition). Oxford University Press. New York.
28. CAMERON, O. G., R. O. ADDY & D. MALITZ. 1985. Effects of ACTH and prednisone on mood: Incidence and time of onset. Int. J. Psychiatry Med. 15: 213-223.
29. WOLKOWITZ, O. M., V. I. REUS, H. WEINGARTNER, K. THOMPSON, A. BREIER, A. R. DORAN, D. RUBINOW & D. PICKAR. 1990. Cognitive effects of corticosteroids. Am. J. Psychiatry 147: 1297-1303.
30. NEWCOMER, J. W., S. CRAFT, T. HERSHEY, K. ASKINS & M. E. BARDGETT. 1994. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 14: 2047-2053.
31. KIRSCHBAUM, C., O. T. WOLF, M. MAY, W. WIPPICH & D. H. HELLHAMMER. 1996. Stress-and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 58: 1475-1483.
32. RECKART, M. D. & S. J. EISENDRATH. 1990. Exogenous corticosteroid effects on mood and cognition. Int. J. Psychosom. 37: 57-61.
33. WOLKOWITZ, O. M. & H. WIENGAMER. 1988. Defining cognitive changes in depression and anxiety: A psychobiological analysis. Psychiatry & Psychobiol. 3: 131S-138S.
34. MCEWEN, B. S. 1982. Glucocorticoids and hippocampus: Receptors in search of a function. In Adrenal actions on brain. D. Ganten & D. Pfaff, Eds.: 1-22. Springer-Verlag. New York.
35. WINOCUR, G. 1980. The hippocampus and cue utilization. Physiol. Psychol. 8: 280-288.
36. WOLKOWITZ, O. M., H. WEINGARTNER, D. RUBINOW, D. JIMERSON, M. KLING, W. BERRET-TINI, K. THOMPSON, A. BREIER, A. DORAN, V. I. REUS & D. PICKAR. 1993. Steroid modulation of human memory: Biochemical correlates. Biol. Psychiatry 33: 744-746.
37. WOLKOWITZ, O. M. 1994. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19: 233-255.
38. BECKWITH, B. E., T. V. PETROS, C. SCAGLIONE & J. NELSON. 1986. Dose-dependent effects of hydrocortisone on memory in human males. Psychology & Behav. 36: 283-286.
39. LUPIEN, S., J. C. GILLIN, D. FRAKES, S. SOEFJE & R. L. HAUGER. 1995. Delayed but not immediate effects of a 100 minutes hydrocortisone infusion on declarative memory performance in young normal adults. Abstracts of the Annual Meeting of the International Society of Psychoneuroendocrinology.
40. MCEWEN, B. S., P. G. DAVIS, B. PARSONS & D. W. PFAFF. 1979. The brain as a target for steroid hormone action. Annu. Rev. Neurosci. 2: 65-112.
41. FEHM-WOLFSDORF, G., E. SCHEIBLE, H. ZENS, J. BOM & H. L. FEHM. 1989. Taste thresholds in man are differentially influenced by hydrocortisone and dexamethasone. Psychoneuroendocrinology 14: 433-440.
42. RUBINOW, D. R., R. M. POST, D. PICKAR, D. NABER, J. C. BALLENGER, P. W. GOLD & W.E. BUNNEY. 1981. Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers. Psychiatry Res. 5: 87-93.
43. NEWCOMER, J. W., W. O. FAUSTMAN, H. A. WHITEFORD, J. A. MOSES, JR. & J. G. CSEMANSKY. 1991. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biol. Psychiatry 29: 855-864.
44. REUS, V. I. 1982. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol. Psychiatry 17: 317-325.
45. LAESSLE, R. G., M. FISCHER, M. M. FICHTER, K. M. PIRKE & J. C. KRIEG. 1992. Cortisol levels and vigilance in eating disorder patients. Psychoneuroendocrinology 17: 475-484.
46. MURPHY, B. E. P., V. DHAR, A. M. GHADIRIAN, G. CHOUINARD & R. KELLER. 1991. Response to steroid suppression in major depression resistant to antidepressant therapy. J. Clin. Psychopharmacol. 11: 121-126.
47. WOLKOWITZ, O. M., V. I. REUS, F. MANFREDI, J. INGBAR & L. BRIZENDINE. 1993. Ketoconazole administration in hypercortisolemic depression. Am. J. Psychiatry 150: 810-812.
48. DEPTULA, D. J. 1983. Lateralized brain dysfunction in depression: An analysis of memory. Diss. Abstr. Int. 44: 3189.
49. STARKMAN, M. N., D. E. SCHTEINGART & M. A. SCHORK. 1981. Depressed mood and other psychiatric manifestations of Cushing's syndrome: Relationship to hormone levels. Psychosom. Med. 43: 3-18.
50. STARKMAN, M. N., D. E. SCHTEINGART & M. A. SCHORK. 1986. Cushing's syndrome after treatment: Changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res. 19: 177-188.
51. MURPHY, B. E. P. & O. M. WOLKOWITZ. 1993. The pathophysiologic significance of hyperadrenocorticism: Antiglucocorticoid strategies. Psychiatr. Ann. 23: 682-690.
52. WOLKOWITZ, O. M. & M. RAPPAPORT. 1989. Long-lasting behavioral reactions following corticosteroid withdrawal. J. A. Med. Assoc. 261: 1731-1732.
53. HASSANYEH, F., R. B. MURRAY & H. RODGERS. 1991. Adrenocortical suppression presenting with agitated depression, morbid jealousy, and a dementia-like state. Br. J. Psychiatry 159: 870-872.
54. FOX, H. M. & S. GIFFORD. 1953. Psychological response to ACTH and cortisone: A preliminary theoretical formulation. Psychosom. Med. 15: 614.
55. CLARK, L. D., W. BAUER & S. COBB. 1952. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N. Engl. J. Med. 246: 205-216.
56. REUS, V. I. & O. M. WOLKOWITZ. 1993. Behavioral side effects of corticosteroid therapy. Psychiatr. Ann. 23: 703-708.
57. FREYBERG, R. H., C. H. TRAEGER, M. PATTERSON, W. SQUIRES, C. H. ADAMS & C. STEVENSON. 1951. Problems of prolonged cortisone treatment for rheumatoid arthritis. J. Am. Med. Assoc. 147: 1538-1543.
58. GLASER, G. H. 1953. Psychotic reactions induced by corticotropin (ACTH) and cortisone. Psychosom. Med. 15: 280-291.
59. DIXON, R. B. & N. P. CHRISTY. 1980. On the various forms of corticosteroid withdrawal syndome. Am. J. Med. 68: 224-230.
60. DUBROVSKY, B. 1993. Effects of adrenal cortex hormones on limbic structures: Some experimental and clinical correlations related to depression. J. Psychiatry & Neurosci. 18: 4-16.
61. MCEWEN, B. S. 1995. Adrenal steroid actions on brain. In Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. M. J. Friedman, D. S. Chaney & A. Y. Deutch, Eds.: 135-147. Lippincott-Raven Publishers. Philadelphia.
62. DIAMOND, D. M., M. C. BENNETT, M. FLESHNER & G. M. ROSE. 1992. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2: 421-430.
63. BENNETT, M. C., D. M. DIAMOND, M. FLESHNER & G. M. ROSE. 1991. Serum corticosterone level predicts the magnitude of hippocampal primed burst potentiation and depression in urethane-anesthetized rats. Psychobiology. 19: 301-307.
64. KOPPELL, B. S., W. K. WITTNER, D. LUNDE, G. WARRICK & D. EDWARDS. 1970. Cortisol effects on averaged evoked potential, alpha-rhythm, time estimation, and two-flash fusion threshold. Psychosom. Med. 32: 39-49.
65. WOLKOWITZ, O. M., R. COPPOLA, A. BREIER, A. R. DORAN, D. RUBINOW, W. H. BERRETTINI, M. A. KLING & D. PICKAR. 1993. Quantitative electroencephalographic correlates of steroid administration in man. Neuropsychobiology 27: 224-230.
66. HENKIN, R. I. 1970. The effects of corticosteroids and ACTH on sensory systems. Prog. Brain Res. 32: 270-294.
67. OADES, R. D. 1979. Search and attention: Interactions of the hippocampal-septal axis, adrenocortical and gonadal hormones. Neurosci. Behav. Rev. 3: 31-48.
68. MICCO, D. J., JR., B. S. MCEWEN & W. SHEIN. 1979. Modulation of behavioral inhibition in appetitive extinction following manipulation of adrenal steroids in rats: Implications for involvement of the hippocampus. J. Comp. Physiol. Psychol. 93: 323-329.
69. SAPOLSKY, R. M. & W. A. PULSINELLI. 1985. Glucocorticoids potentiate ischemic injury to neurons: Therapeutic implications. Science 229: 1397-1400.
70. WOOLLEY, C. S., E. GOULD & B. S. MCEWEN. 1990. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531: 225-231.
71. SAPOLSKY, R. M., L. C. KREY & B. S. MCEWEN. 1986. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr. Rev. 7: 284-301.
72. SAPOLSKY, R. M., H. UNO, C. S. REBERT & C. E. FINCH. 1990. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10: 2897-2902.
73. STARKMAN, M. N., S. S. GEBARSKI, S. BERENT & D. E. SCHTEINGART. 1992. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry 32: 756-765.
74. AXELSON, D. A., P. M. DORAISWAMY, W. M. MCDONALD, O. B. BOYKO, L. A. TUPLER, L. J. PATTERSON, C. B. NEMEROFF, E. H. ELLINWOOD, JR. & K. R. R. KRISHAM. 1993. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 47: 163-173.
75. SAPOLSKY, R. M. 1994. The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann. N.Y. Acad. Sci. 746: 294-307.
76. BARDGETT, M. E., G. T. TAYLOR, J. G. CSEMANSKY, J. W. NEWCOMER & B. NOCK. 1994. Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behav. Neural Biol. 61: 186-190.
77. FALK, W. E., M. W. MAHNKE & D. C. POSKANZER. 1979. Lithium prophylaxis of corticotropin-induced psychosis. J. Am. Med. Assoc. 241: 1011-1012.
78. ABBAS, A. & S. STYRA. 1994. Valproate prophylaxis against steroid induced psychosis. Can. J. Psychiatry. 39: 188-189.
79. LYNN, D. J. 1995. Lithium in steroid-induced depression. Br. J. Psychiatry 166: 264.
80. REUS, V. I., K. DARK, H. VAN PEEKE, R. JOHNSON & O. M. WOLKOWITZ. 1991. Lithium prophylaxis of steroid-induced changes in behavior and neurochemistry. Abstracts of the 46th Annual Meeting of the Society of Biological Psychiatry. New Orleans, Louisiana.
81. GREENBERG, D. B., J. YOUNGER & S. D. KAUFMAN. 1993. Management of lithium in patients with cancer. Psychosomatics 34: 388-394.
82. STIEFEL, F. C., W. S. BREITBART & J. C. HOLLAND. 1989. Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest. 7: 479-491.
83. HALL, R. C. W., M. K. POPKIN & B. KIRKPATRICK. 1978. Tricyclic exacerbation of steroid psychosis. J. Nerv. Ment. Dis. 166: 738-742.
84. BLOCH, M., E. GUR & A. SHALEV. 1994. Chlorpromazine prophylaxis of steroid-induced psychosis. Gen. Hosp. Psychiatry 16: 42-44.
85. LEVENSON, J. A. 1995. Steroid-induced psychosis: Report of case. J. Oral Maxillofac. Surg. 53: 186.
86. DUCORE, J. M., D. A. WALKER, G. EMSLIE & S. J. BERTOLONE. 1983. Acute psychosis complicating induction therapy for acute lymphoblastic leukemia. J. Pediatr. 103: 477-480.
87. GLYNNE-JONES, R., C. C. VERNON & G. BELL. 1986. Is steroid psychosis preventable by divided doses? Lancet 2: 1404.
88. FAUCI, A. S. 1978. Alternate-day corticosteroid therapy. Am. J. Med. 64: 729-731.
89. CORDESS, C., M. FOLSTEIN & D. DRACKMAN. 1981. Psychiatric effects of alternate-day steroid therapy. Br. J. Psychiatry 138: 504-506.
90. SHARFSTEIN, S. S., D. S. SACK & A. S. FAUCI. 1982. Relationship between alternate-day corticosteroid therapy and behavioral abnor malities. J. Am. Med. Assoc. 248: 2987-2989.
91. JOFFE, R. T., K. D. DENICOFF, D. R. RUBINOW, G. TSOKOS, J. E. BALOW & S. E. PILLENER. 1988. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen. Hosp. Psychiatry 10: 56-60.
92. TOMSON, C. R. V. & M. C. VENNING. 1987. Prednisone pharmacokinetics and steroid psychosis. Lancet 1: 270-271.
93. SEIFRITZ, E., U. HEMMETER, W. POLDINGER, E. R. FROESCH, J. M. H. M. REUL & E. HOLSBOER-TRACHSLER. 1995. Differential mood response to natural and synthetic corticosteroids after bilateral adrenalectomy: A case report. J. Psychiatr. Res. 28: 7-11.
94. VAN VOLLENHOVEN, R. F., E. G. ENGLEMAN & J. L. MCGUIRE. 1994. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 37: 1305-1310.
95. KOO, E., F. G. KATALIN, F. TIBOR & E. F. GYOROY. 1987. Experiences with dehydroepiandrosterone therapy in steroid-dependent intrinsic bronchial asthma. Orv. Hetil. 38: 1995-1997.
96. PARKER, L. N. 1989. Adrenal Androgens in Clinical Medicine. Academic Press. San Diego.
97. MORALES, A. J., J. J. NOLAN, J. C. NELSON & S. S. C. YEN. 1994. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78: 1360-1367.
98. WOLKOWITZ, O. M., V. I. REUS, E. ROBERTS, F. MANFREDI, T. CHAN, S. ORMISTON, R. JOHNSON, J. CANICK, L. BRIZENDINE & H. WEINGARTNER. 1995. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann N.Y. Acad. Sci. 774: 337-339.
99. KOHEN, M., R. A. ASHERSON, A. E. GHARAVI & R. G. LAHITA. 1993. Lupus psychosis: Differentiation from the steroid-induced state. Clin. Exp. Rheumatol. 11: 323-326.